Successful immunization with a totally synthetic diphtheria vaccine
about
Crystal structure of a human rhinovirus neutralizing antibody complexed with a peptide derived from viral capsid protein VP2A 20-kilodalton N-terminal fragment of the D15 protein contains a protective epitope(s) against Haemophilus influenzae type a and type b.Epitope-specific protective immunogenicity of chemically synthesized 13-, 18-, and 23-residue peptide fragments of streptococcal M protein.Human antibody response to fragments A and B of diphtheria toxin and a synthetic peptide of amino acid residues 141-157 of fragment APeptide component vaccine engineering: targeting the AIDS virus.HLA-DR: molecular insights and vaccine design.Enhanced epitopic response to a synthetic human malarial peptide by preimmunization with tetanus toxoid carrierInduction of biologically active antibodies by a polyvalent synthetic vaccine constructed without carrierBiologically active antibodies elicited by a synthetic circumsporozoite peptide of Plasmodium knowlesi administered in saline with a muramyl dipeptide derivativeMarked enhancement in vivo of adjuvant activity of muramyl dipeptide to protein antigens and to synthetic weak immunogens with monoclonal anti-muramyl dipeptide antibodies.Enhancement by murabutide of the immune response to natural and synthetic hepatitis B surface antigens.Both cholera toxin-induced adenylate cyclase activation and cholera toxin biological activity are inhibited by antibodies against related synthetic peptides.Site-specific antibodies to human erythropoietin directed toward the NH2-terminal region.Antibodies against synthetic peptides of the B subunit of cholera toxin: crossreaction and neutralization of the toxin.Current trends and advances in bacterial vaccines today.Depressed chemiluminescence response by influenza virus is enhanced after conjugation of viral subunits to muramyl dipeptide.MER5101, a novel Aβ1-15:DT conjugate vaccine, generates a robust anti-Aβ antibody response and attenuates Aβ pathology and cognitive deficits in APPswe/PS1ΔE9 transgenic micePeptides bound to proteosomes via hydrophobic feet become highly immunogenic without adjuvants.Solution conformation of an immunogenic peptide from HRV2: comparison with the conformation found in a complex with a Fab fragment of an anti-HRV2 neutralizing antibody.Synthetic Antigens and Vaccines
P2860
Q27731338-2ADE0BEF-DE5B-4696-841C-7C5A94EB5411Q33756634-C043E0DA-9CD7-4316-8423-B871241C712EQ36267209-A8787590-4445-4A7D-A730-81C59794DED6Q36505082-4BA9F928-78D1-4EFF-A0BD-953802D30C00Q36708999-D23E872B-1E6E-4756-A6D6-C63B426CC587Q36737531-1EFD80BE-2933-4EBD-B921-F6B7F62A24BEQ37007738-19485C9C-761D-4FAA-A102-0FCBA708F006Q37020185-9E3E1407-B168-450E-BB8F-C1CBD55F3DDCQ37034348-5CB24733-6A77-4A41-B997-3570BFB6D050Q37049985-DADCFC2D-3B6D-496C-80CC-F07251FE9041Q37077896-EBFCD710-E291-48E6-802E-CB639A4D35E2Q37580591-4E6EE153-3F0C-4435-B58A-46C907E7792AQ37614895-9DF4A575-4C93-4A77-9FA8-5A865F2F6868Q37690884-EEEEBB09-946F-4990-83F8-D1402F7FF2E1Q39764904-A7AFA050-2770-4931-B05D-156253F08683Q40171239-EB5ACE37-56E2-4899-9C9D-BF18CBB537A8Q41983452-7EA70704-956F-45D7-9438-7631A78D7F70Q42939044-32AE48ED-3FE1-4297-907A-1BB525CCFAACQ47992601-52307280-C50B-49B4-958D-F36C2BEBA161Q58352976-FA183AAD-C331-4CEB-B1BC-E87A79F47F52
P2860
Successful immunization with a totally synthetic diphtheria vaccine
description
1982 nî lūn-bûn
@nan
1982年の論文
@ja
1982年学术文章
@wuu
1982年学术文章
@zh-cn
1982年学术文章
@zh-hans
1982年学术文章
@zh-my
1982年学术文章
@zh-sg
1982年學術文章
@yue
1982年學術文章
@zh
1982年學術文章
@zh-hant
name
Successful immunization with a totally synthetic diphtheria vaccine
@ast
Successful immunization with a totally synthetic diphtheria vaccine
@en
type
label
Successful immunization with a totally synthetic diphtheria vaccine
@ast
Successful immunization with a totally synthetic diphtheria vaccine
@en
prefLabel
Successful immunization with a totally synthetic diphtheria vaccine
@ast
Successful immunization with a totally synthetic diphtheria vaccine
@en
P2093
P2860
P356
P1476
Successful immunization with a totally synthetic diphtheria vaccine
@en
P2093
P2860
P304
P356
10.1073/PNAS.79.16.5042
P407
P577
1982-08-01T00:00:00Z